Literature DB >> 15909997

Transglutaminase activity is present in highly purified nonsynaptosomal mouse brain and liver mitochondria.

Boris F Krasnikov1, Soo-Youl Kim, Stephen J McConoughey, Hoon Ryu, Hui Xu, Irina Stavrovskaya, Siiri E Iismaa, Bryony M Mearns, Rajiv R Ratan, John P Blass, Gary E Gibson, Arthur J L Cooper.   

Abstract

Several active transglutaminase (TGase) isoforms are known to be present in human and rodent tissues, at least three of which, namely, TGase 1, TGase 2 (tissue transglutaminase), and TGase 3, are present in the brain. TGase activity is known to be present in the cytosolic, nuclear, and extracellular compartments of the brain. Here, we show that highly purified mouse brain nonsynaptosomal mitochondria and mouse liver mitochondria and mitoplast fractions derived from these preparations possess TGase activity. Western blotting and experiments with TGase 2 knock-out (KO) mice ruled out the possibility that most of the mitochondrial/mitoplast TGase activity is due to TGase 2, the TGase isoform responsible for the majority of the activity ([14C]putrescine-binding assay) in whole brain and liver homogenates. The identity of the mitochondrial/mitoplast TGase(s) is not yet known. Possibly, the activity may be due to one of the other TGase isoforms or perhaps to a protein that does not belong to the classical TGase family. This activity may play a role in regulation of mitochondrial function both in normal physiology and in disease. Its nature and regulation deserve further study.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15909997      PMCID: PMC2597021          DOI: 10.1021/bi0500877

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  69 in total

1.  Novel protein-disulfide isomerases from the early-diverging protist Giardia lamblia.

Authors:  L A Knodler; R Noiva; K Mehta; J M McCaffery; S B Aley; S G Svärd; T G Nystul; D S Reiner; J D Silberman; F D Gillin
Journal:  J Biol Chem       Date:  1999-10-15       Impact factor: 5.157

2.  Tissue transglutaminase is a multifunctional BH3-only protein.

Authors:  Carlo Rodolfo; Elisabetta Mormone; Paola Matarrese; Fabiola Ciccosanti; Maria Grazia Farrace; Elvira Garofano; Lucia Piredda; Gian Maria Fimia; Walter Malorni; Mauro Piacentini
Journal:  J Biol Chem       Date:  2004-10-12       Impact factor: 5.157

3.  Mutant huntingtin protein: a substrate for transglutaminase 1, 2, and 3.

Authors:  Gina M Zainelli; Nichole L Dudek; Christopher A Ross; Soo-Youl Kim; Nancy A Muma
Journal:  J Neuropathol Exp Neurol       Date:  2005-01       Impact factor: 3.685

4.  Mitochondrial aconitase is a transglutaminase 2 substrate: transglutamination is a probable mechanism contributing to high-molecular-weight aggregates of aconitase and loss of aconitase activity in Huntington disease brain.

Authors:  Soo-Youl Kim; Lyuben Marekov; Parvesh Bubber; Susan E Browne; Irina Stavrovskaya; Jongmin Lee; Peter M Steinert; John P Blass; M Flint Beal; Gary E Gibson; Arthur J L Cooper
Journal:  Neurochem Res       Date:  2005-10       Impact factor: 3.996

5.  Inhibition of select mitochondrial enzymes in PC12 cells exposed to S-(1,1,2,2-tetrafluoroethyl)-L-cysteine.

Authors:  L C Park; G E Gibson; V Bunik; A J Cooper
Journal:  Biochem Pharmacol       Date:  1999-11-15       Impact factor: 5.858

6.  Tissue transglutaminase is increased in Huntington's disease brain.

Authors:  M Lesort; W Chun; G V Johnson; R J Ferrante
Journal:  J Neurochem       Date:  1999-11       Impact factor: 5.372

7.  Polyamine oxidase and tissue transglutaminase activation in rat small intestine by polyamines.

Authors:  P Tunici; A Sessa; E Rabellotti; G Grant; S Bardocz; A Perin
Journal:  Biochim Biophys Acta       Date:  1999-08-05

Review 8.  The alpha-ketoglutarate dehydrogenase complex in neurodegeneration.

Authors:  G E Gibson; L C Park; K F Sheu; J P Blass; N Y Calingasan
Journal:  Neurochem Int       Date:  2000-02       Impact factor: 3.921

9.  Differential expression of multiple transglutaminases in human brain. Increased expression and cross-linking by transglutaminases 1 and 2 in Alzheimer's disease.

Authors:  S Y Kim; P Grant; J H Lee; H C Pant; P M Steinert
Journal:  J Biol Chem       Date:  1999-10-22       Impact factor: 5.157

10.  Transglutaminase aggregates huntingtin into nonamyloidogenic polymers, and its enzymatic activity increases in Huntington's disease brain nuclei.

Authors:  M V Karpuj; H Garren; H Slunt; D L Price; J Gusella; M W Becher; L Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

View more
  16 in total

Review 1.  Transglutaminase 2: a molecular Swiss army knife.

Authors:  Soner Gundemir; Gozde Colak; Janusz Tucholski; Gail V W Johnson
Journal:  Biochim Biophys Acta       Date:  2011-10-10

2.  Reactive gamma-ketoaldehydes formed via the isoprostane pathway disrupt mitochondrial respiration and calcium homeostasis.

Authors:  Irina G Stavrovskaya; Sergei V Baranov; Xiaofeng Guo; Sean S Davies; L Jackson Roberts; Bruce S Kristal
Journal:  Free Radic Biol Med       Date:  2010-06-02       Impact factor: 7.376

3.  Metabolism of the cysteine S-conjugate of busulfan involves a beta-lyase reaction.

Authors:  Arthur J L Cooper; Islam R Younis; Zoya V Niatsetskaya; Boris F Krasnikov; John T Pinto; William P Petros; Patrick S Callery
Journal:  Drug Metab Dispos       Date:  2008-05-12       Impact factor: 3.922

4.  Mitochondrial aconitase is a transglutaminase 2 substrate: transglutamination is a probable mechanism contributing to high-molecular-weight aggregates of aconitase and loss of aconitase activity in Huntington disease brain.

Authors:  Soo-Youl Kim; Lyuben Marekov; Parvesh Bubber; Susan E Browne; Irina Stavrovskaya; Jongmin Lee; Peter M Steinert; John P Blass; M Flint Beal; Gary E Gibson; Arthur J L Cooper
Journal:  Neurochem Res       Date:  2005-10       Impact factor: 3.996

5.  Fluorination at the 4 position alters the substrate behavior of L-glutamine and L-glutamate: Implications for positron emission tomography of neoplasias.

Authors:  Thomas M Jeitner; Eva Kristoferson; Juan A Azcona; John T Pinto; Clint Stalnecker; Jon W Erickson; Hank F Kung; Jianyong Li; Karl Ploessl; Arthur J L Cooper
Journal:  J Fluor Chem       Date:  2016-10-20       Impact factor: 2.050

6.  Physio-pathological roles of transglutaminase-catalyzed reactions.

Authors:  Mariangela Ricotta; Maura Iannuzzi; Giulia De Vivo; Vittorio Gentile
Journal:  World J Biol Chem       Date:  2010-05-26

7.  Mitochondrial P450-dependent arachidonic acid metabolism by TCDD-induced hepatic CYP1A5; conversion of EETs to DHETs by mitochondrial soluble epoxide hydrolase.

Authors:  Erin M Labitzke; Silvia Diani-Moore; Arleen B Rifkind
Journal:  Arch Biochem Biophys       Date:  2007-08-25       Impact factor: 4.013

Review 8.  Cause and consequence: mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases.

Authors:  Gary E Gibson; Anatoly Starkov; John P Blass; Rajiv R Ratan; M Flint Beal
Journal:  Biochim Biophys Acta       Date:  2009-08-26

9.  Expression of Functional Recombinant Human Tissue Transglutaminase (TG2) Using the Bac-to-Bac Baculovirus Expression System.

Authors:  Yaghoub Yazdani; Shahram Azari; Hamid Reza Kalhor
Journal:  Adv Pharm Bull       Date:  2016-03-17

Review 10.  Transglutaminases and neurodegeneration.

Authors:  Thomas M Jeitner; John T Pinto; Boris F Krasnikov; Mark Horswill; Arthur J L Cooper
Journal:  J Neurochem       Date:  2009-05       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.